MAP2K7 and neoplasm: Although the addition of short-term LGK-974 to RAF/MEK inhibition did not reduce tumor burden beyond RAF/MEK inhibition alone (Figure 8—figure supplement 1D), our data show that the biology of residual tumor cells can be manipulated by modulating WNT signaling.